A real-world study of the first use of palbociclib for the treatment of advanced breast cancer within the UK National Health Service as part of the novel Ibrance® Patient Program

Palmieri, C; Musson, A; Harper-Wynne, C; Wheatley, D; Bertelli, G; Macpherson, IR; Nathan, M; McDowall, E; Bhojwani, A; Verrill, M; Eva, J; Doody, C; Chowdhury, R

Palmieri, C (通讯作者),Clatterbridge Canc Ctr NHS Fdn Trust, Liverpool, Merseyside, England.;Palmieri, C (通讯作者),Univ Liverpool, Dept Mol & Clin Canc Med, Liverpool, Merseyside, England.

BRITISH JOURNAL OF CANCER, 2023; 129 (5): 852

Abstract

BACKGROUND: The Ibrance (R) Patient Program was established to provide access to palbociclib for UK National Health Service (NHS) patients with metast......

Full Text Link